300832.SZ Stock Analysis
30
Neutral
Based on Eyestock quantitative analysis, 300832.SZ`s fundamental data and valuation indicate an investment grade of Neutral at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
High score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Overvalued
Shenzhen New Industries Biomedical Engineering Co., Ltd. principally engages in the research, development, production, and sale of automatic chemiluminescence immunoassay instruments and supporting reagents. The company is headquartered in Shenzhen, Guangdong and currently employs 2,298 full-time employees. The company went IPO on 2020-05-12. The firm operates three segments, including Instruments and Supporting Software, Reagents, Accessories and Others. Instruments and Supporting Software segment is involved in the production and sales of MAGLUMI automatic chemiluminescence immunoassay analyzer series products and Biossays automatic biochemical analyzer series products. Reagents segment operates the sales of supporting reagents for the analyzers. The products are applied in the examination of Gonads, thyroid gland, glucose metabolism, kidney function and so on. Accessories and Others segment is responsible for the manufacturing and sales of accessories related to in-vitro diagnostics equipment. The firm sells its products both in domestic and international markets, including Asia, Europe, America and Africa.